Background illustration for clinical trials search

Paid Clinical Trials Quebec City

Discover 363 paid clinical trials in Quebec City, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

for
Multiple Myeloma Refractory, Relapsed Multiple Myeloma
Location: Quebec, Levis
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 18+

Code: NCT07094048

Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Quebec, Sherbrooke, Montreal, Providence RI, Halifax,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase3, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Quebec, Greenfield Park, Ottawa, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Quebec, Montreal, Ottawa, Boston MA, Norwich CT,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Quebec, Greenfield Park, Laval, Montreal, Saint-Jerôme,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

for
Prostate Cancer
Location: Quebec
Sponsor: CHU de Quebec-Universite Laval

Sex: Male

Age: 18+

Code: NCT06052683

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Quebec, Montreal, Ottawa, Syracuse NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

What Are my Options to Stay Safe at Home: Technology For Aging at Home

for
Memory Problems, Aging, Mild Cognitive Impairment,
Location: Quebec, Edmonton
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 65+

Code: NCT04267484

Recruiting

Predicting Psychotic Relapse Using Speech-Based Early Detection

for
Psychosis
Location: Quebec, Montreal, London
Sponsor: Douglas Mental Health University Institute

Sex: All

Age: 16+

Code: NCT06978894

Recruiting

Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors

for
Breast Neoplasms, Breast Cancer
Location: Quebec city
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 18+

Code: NCT05887102

Recruiting

Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)

for
Preterm Birth, Premature Birth, Complication of Prematurity,
Location: Quebec, Sherbrooke, Montreal, Fredericton, Ottawa,
Sponsor: McMaster University

Sex: Female

Age: 18 - 55

Code: NCT05114096

Recruiting

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

for
Rheumatoid Arthritis, Autoimmune Rheumatologic Disease,
Location: Quebec, Montreal
Sponsor: Paul R Fortin

Sex: All

Age: 18+

Code: NCT05236491

Phase2, Phase3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Quebec, Montreal, Ottawa, Moncton, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Quebec, Montreal, Providence RI, Hartford CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase3, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Quebec, Chicoutimi, Montreal, Saint-Jerôme, Albany NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase3, Recruiting

Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students

for
HPV Vaccine
Location: Quebec
Sponsor: Canadian Immunization Research Network

Sex: All

Age: 15 - 17

Code: NCT07156084

Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)

for
Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors,
Location: Quebec, Sherbrooke, Montreal, Hamilton, London
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06960577

Phase2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Quebec, Trois-Rivieres, Sherbrooke, Terrebonne,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Quebec, Montreal, New Haven CT, New York NY, Barrie,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Quebec, Trois-Rivieres, Saint-Charles-Borromee,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06883305

Phase3, Recruiting